They also found that positive Tim-3 expression predicted poor survival in HBV-associated HCC patients, and blocking the interaction between Tim-3 and Gal-9 could increase the function of Tim-3 positive T cells [14]. This evidence concerns the gene HAVCR2 and hepatocellular carcinoma.